Redefining the structure-activity relationships o... [J Med Chem. 2006] - PubMed

Save items

loading

Related citations in PubMed

Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. 5. Opioid receptor binding properties of N-((4'-phenyl)-phenethyl) analogues of 8-CAC. [Bioorg Med Chem Lett. 2007]
Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. 5. Opioid receptor binding properties of N-((4'-phenyl)-phenethyl) analogues of 8-CAC.
VanAlstine MA, Wentland MP, Cohen DJ, Bidlack JM. Bioorg Med Chem Lett. 2007 Dec 1; 17(23):6516-20. Epub 2007 Sep 29.
Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 2: 8-formamidocyclazocine analogues. [Bioorg Med Chem Lett. 2003]
Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 2: 8-formamidocyclazocine analogues.
Wentland MP, Sun X, Ye Y, Lou R, Bidlack JM. Bioorg Med Chem Lett. 2003 Jun 2; 13(11):1911-4.
Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 7: syntheses and opioid receptor properties of cyclic variants of cyclazocine. [Bioorg Med Chem Lett. 2009]
Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 7: syntheses and opioid receptor properties of cyclic variants of cyclazocine.
Wentland MP, Lu Q, Ganorkar R, Zhang SZ, Jo S, Cohen DJ, Bidlack JM. Bioorg Med Chem Lett. 2009 Jan 15; 19(2):365-8. Epub 2008 Nov 24.
Review Recent studies on opioid receptors: heterogeneity and purification. [Ann N Y Acad Sci. 1986]
Review Recent studies on opioid receptors: heterogeneity and purification.
Simon EJ. Ann N Y Acad Sci. 1986; 463:31-45.
Review Opioid use during the perianesthesia period: nursing implications. [J Perianesth Nurs. 2001]
Review Opioid use during the perianesthesia period: nursing implications.
Bennett J, Wren KR, Haas R. J Perianesth Nurs. 2001 Aug; 16(4):255-8.

See reviews... See all...

Cited by 7 PubMed Central articles

Synthesis and opioid receptor binding affinities of 2-substituted and 3-aminomorphinans: ligands for mu, kappa, and delta opioid receptors. [J Med Chem. 2010]
Synthesis and opioid receptor binding affinities of 2-substituted and 3-aminomorphinans: ligands for mu, kappa, and delta opioid receptors.
Decker M, Si YG, Knapp BI, Bidlack JM, Neumeyer JL. J Med Chem. 2010 Jan 14; 53(1):402-18.
Agonist vs antagonist behavior of delta opioid peptides containing novel phenylalanine analogues in place of Tyr(1). [J Med Chem. 2009]
Agonist vs antagonist behavior of delta opioid peptides containing novel phenylalanine analogues in place of Tyr(1).
Berezowska I, Chung NN, Lemieux C, Wilkes BC, Schiller PW. J Med Chem. 2009 Nov 12; 52(21):6941-5.
Syntheses of novel high affinity ligands for opioid receptors. [Bioorg Med Chem Lett. 2009]
Syntheses of novel high affinity ligands for opioid receptors.
Wentland MP, Lou R, Lu Q, Bu Y, Denhardt C, Jin J, Ganorkar R, VanAlstine MA, Guo C, Cohen DJ, et al. Bioorg Med Chem Lett. 2009 Apr 15; 19(8):2289-94. Epub 2009 Feb 25.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
BioAssay
PubChem BioAssay experiments on the biological activities of small molecules that cite the current articles. The depositors of BioAssay data provide these references.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. 4...
Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. 4. Opioid receptor binding properties of 8-[N-(4'-phenyl)-phenethyl)carboxamido] analogues of cyclazocine and ethylketocycalzocine.
J Med Chem. 2006 Sep 7 ;49(18):5635-9.

PubMed
Anatomical investigation of projections from thalamus to posterior parietal cort...
Anatomical investigation of projections from thalamus to posterior parietal cortex in the rhesus monkey: a WGA-HRP and fluorescent tracer study.
J Comp Neurol. 1990 May 8 ;295(2):299-326.

PubMed
Integrated MEG/EEG and fMRI model based on neural masses.
Integrated MEG/EEG and fMRI model based on neural masses.
IEEE Trans Biomed Eng. 2006 Sep ;53(9):1794-801.

PubMed
Activated protein kinase C directly phosphorylates the CD34 antigen on hematopoi...
Activated protein kinase C directly phosphorylates the CD34 antigen on hematopoietic cells.
J Biol Chem. 1990 Jul 5 ;265(19):11056-61.

PubMed
Topiramate monotherapy in infantile spasm.
Topiramate monotherapy in infantile spasm.
Yonsei Med J. 2006 Aug 31 ;47(4):498-504.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. 4. Opioid receptor binding properties of 8-[N-(4'-phenyl)-phenethyl)carboxamido] analogues of cyclazocine and ethylketocycalzocine.

Source

Abstract

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Grant Support

LinkOut - more resources

Full Text Sources

Other Literature Sources

Chemical Information

Supplemental Content

Save items

Related citations in PubMed

Cited by 7 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information